Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants

Anya Topiwala, Klaus P. Ebmeier, Thomas Maullin-Sapey, Thomas E. Nichols
doi: https://doi.org/10.1101/2021.05.10.21256931
Anya Topiwala
1Senior Clinical Researcher, Nuffield Department Population Health, Big Data Institute, University of Oxford, Oxford, UK, OX3 7LF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anya.topiwala@bdi.ox.ac.uk
Klaus P. Ebmeier
2Professor of Old Age Psychiatry, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK, OX3 7JX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Maullin-Sapey
3Doctoral researcher, Nuffield Department Population Health, Big Data Institute, University of Oxford, Oxford, UK, OX3 7LF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Nichols
4Professor of Neuroimaging Statistics, Nuffield Department Population Health, Big Data Institute, University of Oxford, Oxford, UK, OX3 7LF
5Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To estimate the relationship between moderate alcohol consumption and brain health, determining the threshold intake for harm and identifying whether population subgroups are at differential risk.

Design Observational cohort study. Alcohol consumption was determined at baseline assessment visit using touchscreen questionnaire (2016-10). Multi-modal MRI brain and cognitive testing were performed subsequently (2014-20). Clinical data was extracted from linked Hospital Episode Statistics.

Setting UK Biobank study. Brain imaging was performed on identical scanners with identical protocols at three UK centres (2014-20).

Participants 25,378 participants (mean age 54.9±7.4 years).

Main outcome measures Brain health as defined by structural and functional MRI brain measures.

Results Alcohol consumption was negatively linearly associated with global brain grey matter volume (beta= -0.1, 95%CI= -0.11 to -0.09, p<2×10−16). The association with alcohol was stronger than other modifiable factor tested and robust to unobserved confounding. Widespread negative associations were observed with white matter microstructure (beta= -0.08, 95%CI= -0.09 to -0.06, p<2×10−16) and positive correlations with functional connectivity. Higher blood pressure and body mass index increased risk of alcohol-related harm (SBP*alcohol: beta= - 0.01, 95%CI = -0.02 to -0.004, p=0.005; BMI*alcohol: beta= -0.01, 95%CI = -0.02 to -0.002, p=0.02). Binging on alcohol had additive negative effects on brain structure on top of the absolute volume consumed (daily compared to never binging: beta= -0.19, 95%CI= -0.30 to -0.08, p<0.01). No evidence was found for differential effects of drinking wine, beer or spirits.

Conclusions No safe dose of alcohol for the brain was found. Moderate consumption is associated with more widespread adverse effects on the brain than previously recognised. Individuals who binge drink or with high blood pressure and BMI may be more susceptible. Detrimental effects of drinking appear to be greater than other modifiable factors. Current ‘low risk’ drinking guidelines should be revisited to take account of brain effects.

Funding AT is supported by a Wellcome Trust fellowship (216462/Z/19/Z). KPE is supported by the UK Medical Research Council (G1001354) and the European Commission (Horizon 2020 732592). This work was also supported by the Li Ka Shing Centre for Health Information and Discovery and NIH grant (TMS, TN: R01EB026859) and a Wellcome Trust award (TN: 100309/Z/12/Z).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

AT is supported by a Wellcome Trust fellowship (216462/Z/19/Z). KPE is supported by the UK Medical Research Council (G1001354) and the European Commission (Horizon 2020 732592). This work was also supported by the Li Ka Shing Centre for Health Information and Discovery and NIH grant (TMS, TN: R01EB026859) and a Wellcome Trust award (TN: 100309/Z/12/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UKB approval was obtained from the North West Multi-Centre Research Ethics Committee and the Patient Information Advisory Group. The UKB Board and Access Sub-Committee and the Biobank Ethics and Governance Council reviewed our data access application.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available to researchers affiliated with academic centres upon successful application to the UK access committee.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants
Anya Topiwala, Klaus P. Ebmeier, Thomas Maullin-Sapey, Thomas E. Nichols
medRxiv 2021.05.10.21256931; doi: https://doi.org/10.1101/2021.05.10.21256931
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants
Anya Topiwala, Klaus P. Ebmeier, Thomas Maullin-Sapey, Thomas E. Nichols
medRxiv 2021.05.10.21256931; doi: https://doi.org/10.1101/2021.05.10.21256931

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (221)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)